Biofrontera FDA approves Ameluz for skin cancer treatment
Biofrontera announced FDA approval of Ameluz for superficial basal cell carcinoma, expanding the therapy's market reach. This approval establishes it as the only FDA-approved photo…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Biofrontera announced FDA approval of Ameluz for superficial basal cell carcinoma, expanding the therapy's market reach. This approval establishes it as the only FDA-approved photo…
Cardiff Oncology, Inc. has executed an amendment to its license agreement with Nerviano Medical Sciences, effectively resolving ongoing legal disputes. This is a significant develo…
Ellington Financial Inc. plans to issue $100 million of 7.375% senior unsecured notes due 2030 through its subsidiaries. The company intends to use the net proceeds for general cor…
Healthstream Inc. and its lenders entered into a Second Amendment to the Amended and Restated Revolving Credit Agreement dated October 6, 2023, effective as of September 10, 2026. …
Baldwin Insurance Group signed a definitive agreement to merge with Square Acquisition Parent in a deal valuing the company. The transaction is valued at approximately $597.5 milli…
XBP Global Holdings announced a securities purchase agreement for financing, dated September 11, 2026. The company intends to sell securities to a group of purchasers. This transac…
Immersion Corp reported $294.4 million in Q1 Fiscal 2027 revenue and GAAP net income of $4.9 million, highlighting continued financial strength following its strategic investment i…
Phio Pharmaceuticals announced a formal submission to the U.S. FDA regarding nonclinical and clinical data for PH-762, intending to progress to a Phase 2b trial. This filing is a k…
Hyperliquid Strategies Inc amended a purchase agreement with Chardan Capital Markets to adjust the VWAP Purchase Price to 98.5% for standard trades and 97% for off-hour trades, ind…
Future Vision II signed an unsecured promissory note with HWei Super Speed Co. Ltd., secured by a one-month extension to its business combination deadline due to the funds being de…
Bitmine reported total crypto, cash, and securities assets of $15.8 billion, including 4.9% of the Ethereum supply, representing major strategic holdings and position at 98% of the…
Summit's partner Akeso announced Phase III data showing ivonescimab significantly improved survival over pembrolizumab in PD-L1 positive patients, prompting the company to proceed …
Bowman Consulting Group's go-shop period expired without receiving a superior proposal, leaving the previously announced all-cash $43.00 per share deal with Bernhard Capital Partne…
DeFi Dev Corp added 55,491 SOL to its treasury to reach 2.39 million, and announced an ATM offering for up to $300M of Series C Preferred Stock to fund further SOL purchases.
Eos Energy Enterprises received an $87 million advance to fund its Line 2 at the Thorn Hill facility, bringing total DOE draws to $178 million, which is essential for scaling U.S. …
The company issued a forward-looking update on September 2026 regarding future financial results, loan performance, and sector risks. This release highlights factors that could aff…
Dr. Albert Luderer, PhD, assumed the roles of Chairman and Interim Chief Executive Officer at Bionano Genomics effective September 14, 2026.
Graco Inc. announced it has appointed Richard B. Lewis, President and CEO of Donaldson Company, to its Board of Directors, effective December 3, 2026.
Enbridge Inc. intends to sell common shares under an underwriting agreement with RBC and CIBC. The move is a standard capital raising activity for the company.
NETSTREIT Corp. provided an investor presentation outlining forward-looking business outlooks, growth strategies, and non-GAAP financial measures. The update highlights the company…